Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00380185 · ClinicalTrials.gov registry record
Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 1,789
- Enrollment target
NCT00380185: Completed study, sponsored by Stanford University.
NCT00380185 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 1,789 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00380185 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 1,789 participants
- Enrollment target
Study Summary
Atherosclerosis, a condition in which fatty deposits build up along the inner walls of arteries, can occur throughout the body. The purpose of this study is to examine the possible genetic differences that may influence where atherosclerosis occurs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,789 participants |
| Start Date | 2004-04 |
What the finished NCT00380185 record still lists
NCT00380185 is an observational study that tracks outcomes without assigning an intervention. Its 1,789 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00380185 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00380185 about?
NCT00380185 is a clinical study titled "Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease". Atherosclerosis, a condition in which fatty deposits build up along the inner walls of arteries, can occur throughout the body. The purpose of this study is to examine the possible genetic differences that may influence where atherosclerosis occurs.
What is the current status of trial NCT00380185?
This trial is currently completed. The enrollment target is 1,789 participants. The study started on 2004-04.
Who is sponsoring clinical trial NCT00380185?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05770570 · 1,785 participants · Phase 2
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
- NCT03067181 · 1,780 participants · Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- NCT06526650 · 1,780 participants · NA
'Ai Pono Cooking Demonstrations
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia